Streetbeat News

Products Services

GOOG

GOOGL

Alphabet Inc.'s Google is offering a deal on its Pixel 8 Pro, which includes the phone, the Pixel Watch 2, 12 months of mobile service, and additional savings of $170. The deal is available through a Mint Mobile bundle. Buyers can pay $77 per month or $919 upfront, with additional discounts for those who opt for the 12-month data plan.

Portfolio Pulse from Rounak Jain

October 16, 2023 | 12:20 pm

ENPH

Enphase Energy, Inc. (NASDAQ:ENPH) has started shipping its IQ8 Microinverters in India. These microinverters are designed to support high-powered solar modules and maximize energy production. The products come with a 15-year limited warranty that can be extended up to 25 years. The company's Energy System integrates with the IQ Gateway, enabling over-the-air updates and connection to the Enphase App monitoring platform.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:20 pm

ENTX

Entera Bio Ltd. (NASDAQ:ENTX) presented two posters at the Annual Society of Bone and Mineral Research (ASBMR) 2023 Annual Meeting, showcasing the consistent delivery and rapid biological responses of its oral PTH(1-34) peptide in a mini tablet format. The company's lead drug candidate, EB613, is being developed as a once-daily oral therapy for osteoporosis. A Phase 2 study showed that EB613 produced rapid changes in biochemical markers and increased Bone Mineral Density in postmenopausal women with osteoporosis. A Phase 1 study comparing oral EB613 and other treatments is ongoing.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:20 pm

CATX

Perspective Therapeutics has completed recruitment for the first patient cohort in its Phase 1/2a dose escalation study of 212Pb-VMT01, a targeted alpha-particle therapy for the treatment of MC1R-positive metastatic melanoma. The trial is a multi-center open-label dose escalation, dose expansion study of 212Pb-VMT01 in subjects with histologically confirmed melanoma and positive MC1R imaging scans. The first part of the study is a dose escalation phase to determine the Maximum Tolerated radioactivity Dose (MTD) or Maximum Feasible radioactivity Dose (MFD) following a single administration of 212Pb-VMT01.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:19 pm

AAPL

GNS

META

Genius Group Limited (NYSE:GNS) has announced a joint venture with RetreatVR to develop the Genius Metaversity ‘Life Campus', a virtual reality education application on the Meta VR Store. The Life Campus will be the latest addition to Genius Group's Edtech platform, GeniusU, which serves 5.4 million students globally. The joint venture aims to combine GeniusU's platform, students, and partners with RetreatVR's courses and partners. The Life Campus will initially be built on Genius Metaversity, accessible via PC and laptop via GeniusU, and then also be accessible with the next generation of VR headsets as an app on the Meta Store and Apple Vision Pro platform.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:18 pm

EQ

Equillium Inc. (NASDAQ:EQ) presented preclinical data on EQ302, a second generation orally deliverable multi-cytokine inhibitor, at the 18th Annual Peptide Therapeutics Symposium. EQ302 is designed to target IL-15 and IL-21 and is being developed for potential use in treating various gastrointestinal diseases. The data showed that EQ302, when administered orally to mice, inhibited IL-15-induced IFNγ transcription in the gastrointestinal tract, indicating potential utility for Celiac Disease and inflammatory bowel disease.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:16 pm

IOVA

Iovance Biotherapeutics has announced clinical data for Lifileucel in advanced mucosal melanoma at the European Society for Medical Oncology Congress. The data is expected to have significant implications for the company's future developments.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:16 pm

IAS

Integral Ad Science (NASDAQ:IAS), a global media measurement and optimization platform, has launched a new AI-driven site detection and avoidance product. The technology aims to improve transparency into advertiser campaign quality, identify where spend is being allocated, and minimize waste on Made for Advertising (MFA) sites. MFA sites are web pages featuring low quality content created solely to serve ads. The new product allows advertisers to take control of their media quality and cut down on wasted spend. The product completed alpha testing in early October 2023, and is available now as a beta measurement offering for select customers. General availability is expected to expand to all customers in early 2024.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:15 pm

TERN

Terns Pharmaceuticals has announced the design of a global Phase 1 clinical trial for TERN-701, a treatment for chronic myeloid leukemia. The U.S. Food and Drug Administration has cleared the Investigational New Drug application. The design is based on insights from an ongoing Phase 1 trial in China. Patient screening is expected to start in December 2023, with initial data expected in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:15 pm

SQ

Square Inc (NASDAQ:SQ) has announced a partnership with Jane Technologies, an online ordering service for cannabis dispensaries, to develop commerce solutions for the growing recreational cannabis industry in Canada. The move is part of Square's strategy to solve sellers' pain points and navigate the complex regulatory landscape of the cannabis industry. The company is also considering expansion into more provinces in Canada and exploring ways to offer sellers more products at competitive price points. The partnership with Jane Technologies is seen as a significant opportunity to create better business solutions for the recreational cannabis industry in Canada.

Portfolio Pulse from Javier Hasse

October 16, 2023 | 12:13 pm